
Analysis of a large, nationally representative claims database to longitudinally monitor enrollees with hepatitis B showed that 36% received recommended care and 18% were prescribed treatment.
Analysis of a large, nationally representative claims database to longitudinally monitor enrollees with hepatitis B showed that 36% received recommended care and 18% were prescribed treatment.
Published: August 12th 2020 | Updated:
259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512
© 2025 MJH Life Sciences®
All rights reserved.